mdlinx mdlinx
Latest (257) Full Text Articles (9654) Focus on Angina Article Summary

Efficacy and gastrointestinal risk of aspirin used for the treatment of pain and cold
Best Practice & Research Clinical Gastroenterology , 05/04/2012  Clinical Article

McCarthy DM – Over–the–counter (OTC) aspirin is safe and effective. Safety concerns should not limit brief use to relieve acute pain, cold or fever.

Methods
  • Evidence was largely collected from published meta–analyses and systematic reviews that focused on randomised, controlled, double–blind clinical trials, in which aspirin was compared to placebo and, in some cases also, to active comparators such as OTC doses of paracetamol or ibuprofen.

Results
  • Across a large number of comparisons, aspirin was superior to placebo in treating pain, cold or fever.
  • Efficacy was essentially similar to that of comparators used in equivalent doses.
  • There was no serious GI adverse event attributed to ASA in any study, but mild–to–moderate dyspepsia in small percentages of cases was commonly reported.

► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

Last month's top read Top Articles of 2012

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Other Topics in Internal Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close